Cytokinetics, Incorporated
IT ˙ BIT ˙ US23282W6057
62,32 € 0,00 (0,00%)
2026-06-05
DEL PRIS
SecurityIT:1CYTK / Cytokinetics, Incorporated
InstitutionProShare Advisors LLC
Latest Disclosed Ownership27,777 shares
Latest Disclosed Value $ 1,830,782
ProShare Advisors LLC reports 13.79% decrease in ownership of 1CYTK / Cytokinetics, Incorporated

On April 24, 2026 - ProShare Advisors LLC filed a 13F-HR form disclosing ownership of 27,777 shares of Cytokinetics, Incorporated (IT:1CYTK) valued at $1,499,958 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 32,219 shares of Cytokinetics, Incorporated. This represents a change in shares of -13.79% during the quarter. The current value of the position is $1,731,063 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F CYTOKINETICS COM NEW 23282W605 27,777 -4,442 -13.79 1,831 -10.60 0.0027
2026-02-06 2025-12-31 13F CYTOKINETICS COM NEW 23282W605 32,219 2,889 9.85 2,047 27.06 0.0036
2025-11-06 2025-09-30 13F CYTOKINETICS COM NEW 23282W605 29,330 -4,380 -12.99 1,612 44.74 0.0034
2025-08-07 2025-06-30 13F CYTOKINETICS COM NEW 23282W605 33,710 -1,405 -4.00 1,114 -21.12 0.0022
2025-05-08 2025-03-31 13F CYTOKINETICS COM NEW 23282W605 35,115 -8,184 -18.90 1,411 -30.70 0.0032
2025-02-14 2024-12-31 13F CYTOKINETICS COM NEW 23282W605 43,299 9,620 28.56 2,037 14.51 0.0047
2024-11-14 2024-09-30 13F CYTOKINETICS COM NEW 23282W605 33,679 7,112 26.77 1,778 23.56 0.0044
2024-08-13 2024-06-30 13F CYTOKINETICS COM NEW 23282W605 26,567 -2,600 -8.91 1,439 -29.60 0.0039
2024-05-08 2024-03-31 13F CYTOKINETICS COM NEW 23282W605 29,167 5,313 22.27 2,045 2.66 0.0054
2024-02-14 2023-12-31 13F CYTOKINETICS COM NEW 23282W605 23,854 3,342 16.29 1,992 229.64 0.0061
2023-11-13 2023-09-30 13F CYTOKINETICS COM NEW 23282W605 20,512 -287 -1.38 604 -10.91 0.0019
2023-08-10 2023-06-30 13F CYTOKINETICS COM NEW 23282W605 20,799 1,993 10.60 678 2.57 0.0020
2023-05-26 2023-03-31 13F/A-1 CYTOKINETICS COM NEW 23282W605 18,806 -2,343 -11.08 662 -31.79 0.0020
2023-05-12 2023-03-31 13F CYTOKINETICS COM NEW 23282W605 18,806 -2,343 662 0.0021
2023-02-02 2022-12-31 13F CYTOKINETICS COM NEW 23282W605 21,149 1,615 8.27 969 2.32 0.0034
2022-11-07 2022-09-30 13F CYTOKINETICS COM NEW 23282W605 19,534 1,192 6.50 947 31.35 0.0036
2022-08-01 2022-06-30 13F CYTOKINETICS COM NEW 23282W605 18,342 -8,232 -30.98 721 -26.35 0.0024
2022-05-10 2022-03-31 13F CYTOKINETICS COM NEW 23282W605 26,574 -5,188 -16.33 979 -32.39 0.0021
2022-02-08 2021-12-31 13F CYTOKINETICS COM NEW 23282W605 31,762 1,601 5.31 1,448 34.32 0.0028
2021-11-12 2021-09-30 13F CYTOKINETICS COM NEW 23282W605 30,161 -2,347 -7.22 1,078 67.65 0.0030
2021-08-13 2021-06-30 13F CYTOKINETICS COM NEW 23282W605 32,508 2,815 9.48 643 -6.95 0.0019
2021-05-14 2021-03-31 13F CYTOKINETICS COM NEW 23282W605 29,693 2,715 10.06 691 23.17 0.0022
2021-02-09 2020-12-31 13F CYTOKINETICS COM NEW 23282W605 26,978 6,212 29.91 561 24.67 0.0021
2020-11-13 2020-09-30 13F CYTOKINETICS COM NEW 23282W605 20,766 2,659 14.68 450 5.39 0.0021
2020-08-03 2020-06-30 13F CYTOKINETICS COM NEW 23282W605 18,107 5,757 46.62 427 192.47 0.0023
2020-05-15 2020-03-31 13F CYTOKINETICS COM NEW 23282W605 12,350 -9,597 -43.73 146 -37.34 0.0010
2020-02-12 2019-12-31 13F CYTOKINETICS COM NEW 23282W605 21,947 -1,763 -7.44 233 -13.70 0.0011
2019-11-12 2019-09-30 13F CYTOKINETICS COM NEW 23282W605 23,710 317 1.36 270 2.66 0.0015
2019-08-13 2019-06-30 13F CYTOKINETICS COM NEW 23282W605 23,393 -1,769 -7.03 263 28.92 0.0016
2019-05-15 2019-03-31 13F CYTOKINETICS COM NEW 23282W605 25,162 243 0.98 204 29.94 0.0012
2019-02-14 2018-12-31 13F CYTOKINETICS COM NEW 23282W605 24,919 -4,362 -14.90 157 -45.49 0.0011
2018-11-14 2018-09-30 13F CYTOKINETICS COM NEW 23282W605 29,281 -1,197 -3.93 288 13.83 0.0020
2018-08-13 2018-06-30 13F CYTOKINETICS COM NEW 23282W605 30,478 -1,316 -4.14 253 10.48 0.0017
2018-05-14 2018-03-31 13F CYTOKINETICS COM NEW 23282W605 31,794 -4,941 -13.45 229 -23.41 0.0015
2018-02-14 2017-12-31 13F CYTOKINETICS COM NEW 23282W605 36,735 2,670 7.84 299 -39.47 0.0021
2017-11-13 2017-09-30 13F CYTOKINETICS COM NEW 23282W605 34,065 6,564 23.87 494 48.35 0.0045
2017-08-11 2017-06-30 13F CYTOKINETICS COM NEW 23282W605 27,501 1,926 7.53 333 1.22 0.0033
2017-05-12 2017-03-31 13F/A-2 CYTOKINETICS COM NEW 23282W605 25,575 -6,632 -20.59 329 -15.86 0.0034
2017-05-08 2017-03-31 13F/A-1 CYTOKINETICS COM NEW 23282W605 25,575 0 329 0.0034
2017-04-25 2017-03-31 13F CYTOKINETICS COM NEW 23282W605 25,575 329
2017-02-13 2016-12-31 13F CYTOKINETICS COM NEW 23282W605 32,207 32,207 0.00 391 0.0043
2015-01-30 2014-12-31 13F CYTOKINETICS COM NEW 23282W605 0 -13,582 -100.00 0 -100.00
2014-11-06 2014-09-30 13F CYTOKINETICS COM NEW 23282W605 13,582 -3,072 -18.45 48 -40.00 0.0006
2014-08-08 2014-06-30 13F CYTOKINETICS COM NEW 23282W605 16,654 -14,453 -46.46 80 -72.97 0.0010
2014-05-07 2014-03-31 13F CYTOKINETICS COM NEW 23282W605 31,107 31,107 84.70 296 131.25 0.0037
2014-02-04 2013-12-31 13F CYTOKINETICS COM NEW 23282W605 0 -16,842 -100.00 0 -100.00
2013-11-07 2013-09-30 13F CYTOKINETICS COM NEW 23282W605 16,842 16,842 128 0.0030
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.